InsightsPremium
Aligos Therapeutics logo

Aligos Therapeutics

0 Followers

Org chart

Lawrence M. Blatt
Chief Executive Officer and Director
Lawrence M. Blatt
Collapse
Leonid Beigelman
President and Director
Lesley Ann Calhoun
EVP, CFO
Lucinda Y. Quan
EVP, Chief Business Officer and General Counsel
Julian A. Symons
EVP, Chief Scientific Officer
Matthew W. McClure
EVP, Chief Medical Officer
David B. Smith
EVP, Head of Chemical Operations
Pierre J.M.B. Raboisson
EVP, Head of Small Molecule Medicinal Chemistry, Head of Belgium Site (Leuven)
John Fry
EVP, Clinical Development
Sushmita M. Chanda
EVP, Translational Safety Sciences

Board & Advisors

Jack B. Nielsen
Chair and Director
Carole Nuechterlein
Director
Peter Moldt
Director
K. Peter Hirth
Director
Kathleen Sereda Glaub
Director
Thomas Woiwode
Director
Profile photo of James Scopa, Director at Aligos Therapeutics
James Scopa
Director

Positions not yet in org chart

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.